Inventurus Knowledge Solutions Limited
CLOSEDIPO Date: 12 Dec - 16 Dec 2024
Listing Date: 19 Dec 2024
Price Range
₹1265 to ₹1329 per share
Issue Size
2497.92 Cr
Min Investment
₹13,915
Lot Size
11 Shares
Schedule of Inventurus Knowledge Solutions Limited
Issue open date
12 Dec 2024
Issue close date
16 Dec 2024
UPI mandate deadline
16 Dec 2024 (5 PM)
Allotment finalization
17 Dec 2024
Share credit
18 Dec 2024
Listing date
19 Dec 2024
Mandate end date
31 Dec 2024
Issue size
| Funds Raised in the IPO | Amount |
|---|---|
| Overall | 2497.92 Cr |
| Fresh Issue | 0 Cr |
| Offer for Sale | 0 Cr |
Allotment DetailsNew
| Allotment Timeline | Details |
|---|---|
| Allotment Date | 17 Dec 2024 |
| Allotment Link | {Link} |
Grey Market PremiumNew
Grey Market Premium (GMP) is the premium at which the shares are traded in the grey market. It gives a fair idea about the listing price of the IPO shares. The GMP can be positive or negative based on the demand and supply of the shares in the grey market.
| Date | Ipo Price | GMP | Estimated Listing Price |
|---|
Performance Inventurus Knowledge Solutions Limited
| Issue Price | Listing Gain | Current Market Price | P/L |
|---|---|---|---|
| ₹1265 to ₹1329 per share | ₹ 26381 (41.9%) | ₹ 1732.15 | 30.33% |
About Inventurus Knowledge Solutions Limited
Incorporated in 2006, Inventurus Knowledge Solutions Limited (IKS Health) provides services to healthcare enterprises such as handling administrative chores/work. The company helps doctors and other healthcare providers by handling their paperwork and administrative tasks. IKS Health offers services such as clinical support, medical documentation management, virtual medical scribing and more.The company is a healthcare technology company that helps make it easier and faster for patients to get the care they need while reducing the administrative burden on healthcare providers.Inventurus Knowledge Solutions Limited offer a platform that enables healthcare enterprises in outpatient and inpatient care.- Outpatient service facilities, also known as ambulatory care, provide medical care without requiring admission to a hospital or other facility and include observation, consultation, diagnosis, rehabilitation, intervention, and treatment services.- Inpatient care refers to the provision of medical treatment for patients who have been admitted to a hospital or medical facility, requiring an overnight stay or an extended duration.As of September 30, 2024, IKS serves over 778 healthcare organizations, including health systems, multi-specialty medical groups, and other outpatient and inpatient providers. Key clients include Mass General Brigham Inc., Texas Health Care PLLC, and The GI Alliance Management.The company has a team of over 13,528 employees, including 2,612 clinically-trained professionals, and a consultative sales force operating in the US, Canada, and Australia.
| Founded in | 2006 |
| Managing director | |
| Parent organization |
Financial Overview
Strengths
- Comprehensive one-stop platform with diversified offerings across the outpatient and inpatient care value chain serving key stakeholders such as patients, physicians, nurses and healthcare organizations.
- Leveraging digital evolution, transformation and automation technologies to create sustained value based on outcomes delivered.
- Strong brand amongst healthcare organizations and physicians.
- Sustainable and scalable business model offering clients flexibility and cost-savings and high-touch 215 engagement through access to project executive sponsors and leadership teams creating cross-selling opportunities.
Risks
Subscription Figures
| Category | Subscription (No. of times) |
|---|---|
| Qualified Institutional Buyers (QIBs) | 80.64 |
| Non-Institutional Investors (NIIs) | 23.25 |
| Retail Individual Investors (RIIs) | 14.55 |
| Employee | N/A |
| Total | 52.68 |